Lithium in maintenance therapy for bipolar disorder

Journal of Psychopharmacology

Volumn 20, Issue 2 SUPPL., 2006, Pages 17-22

  Young, Allan H ^a   Newham, James I ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Bipolar disorder; Effectiveness; Efficacy; Lithium; Maintenance; Suicide

Indexed keywords

LAMOTRIGINE; LITHIUM;

ABDOMINAL DISCOMFORT; ACNE; BIPOLAR DISORDER; BLURRED VISION; CEREBELLAR ATAXIA; CHOREA; CLINICAL TRIAL; COMA; CONFERENCE PAPER; DEPRESSION; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; FASCICULATION; FATIGUE; HUMAN; HYPERREFLEXIA; HYPOTHYROIDISM; INCONTINENCE; KIDNEY DISEASE; MACULOPAPULAR RASH; MAINTENANCE THERAPY; MEMORY DISORDER; META ANALYSIS; MUSCLE WEAKNESS; NAUSEA; PARKINSONISM; PERIPHERAL NEUROPATHY; POLYURIA; PRIORITY JOURNAL; PSORIASIS; PSYCHOSIS; SEIZURE; SIDE EFFECT; SOMNOLENCE; SUICIDE; SYSTEMATIC REVIEW; TASTE DISORDER; THIRST; THYROID DISEASE; TREMOR; WEIGHT GAIN;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; LITHIUM CARBONATE; LONG-TERM CARE; META-ANALYSIS; RECURRENCE; SUICIDE; TREATMENT OUTCOME;

EID: 33645109623     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806063072     Document Type: Conference Paper

References (22)

1. Bauer M, Döpfmer S (1999) Lithium augmentation in treatment-resistant depression: a meta-analysis of placebo-controlled studies. Journal of Clinical Psychopharmacology 19: 427-434
2. Bowden C L, Ghaemi N, Guylai L, Huey L, Khan A, Montgomery P, Ascher J A (2002) Lamotrigine delays mood episodes in recently depressed bipolar I patients. in 2002 Annual Meeting New Research Program and Abstracts. APA, Washington, DC, p. 81
3. Bowden C L, Calabrese J R, McElroy S L, Gyulai L, Wassef A, Petty F, Pope H G Jr, Chou J C, Keck P E Jr, Rhodes L J, Swann A C, Hirschfield R M, Wozniak P J (Divalproex Maintenance Study Group) (2000) A randomised, placebo-controlled 12 month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 57: 481-489
4. Bowden C L, Calabrese J R, Sachs G, Yatham L N, Asghar S, Hompland M, Montgomery P, Earl N, Smoot T M, DeVeaugh-Greiss, (Lamictal 606 Study Group) (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60: 392-400
5. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G (2001) Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 3: CD003013
6. Geddes J R, Burgess S, Hawton K, Jamison K, Goodwin G M (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161: 217-222
7. Ghose K (1977) Lithium salts: therapeutic and unwanted effects. British Journal of Hospital Medicine 18 (6): 578-583
8. Goodwin G M (1994) Recurrence of mania after lithium withdrawal: implications for the use of lithium in the treatment of bipolar affective disorder. British Journal of Psychiatry 164: 149-152
9. Hughes J H, Dunne F, Young A H (2000) Effects of acute tryptophan depletion on mood and suicidal ideation in bipolar patients symptomatically stable on lithium. Br J Psychiatry 177: 447-451
10. Kane J M, Quitkin F M, Rifkin A, Ramos L Jr, Nayak D D, Howard A (1982) Lithium carbonate and impipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 39: 1065-1069
11. Macritchie K A N, Young A H (2004) Adverse syndromes associated with lithium. In Haddad P, Dursun S, Deakin B (eds), Adverse syndromes and psychiatric drugs. A clinical guide. Oxford University Press, pp. 89-109
12. Mander A J, Loudon J B (1988) Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 2: 15-17
13. Markar H R, Mander A J (1989) Efficacy of lithium prophylaxis in clinical practice. Br J Psychiatry 155: 496-500
14. Markowitz G S, Radhakrishnan J, Kambham N, Valeri A M, Hines W H, D'Agati V D (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. Journal of the American Society of Nephrology 11: 1439-1448
15. Moncrieff J (1995) Lithium revisited: a re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. British Journal of Psychiatry 167: 569-574
16. Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush A J (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 156(8): 1164-1169
17. Suppes T, Baldessarini R J, Faedda G L (1991) Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 48: 1082-1088
18. Thompson J M, Gallagher P, Hughes J H, Watson S, Gray J M, Ferrier I N, Young A H (2005) Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 186: 32-40
19. Tohen M, Ketter T A, Zarate C A, Suppes T, Frye M, Altshuler L, Zajecka J. Schuh L M, Risser R C, Brown E, Baker R W (2003) Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 160(7): 1263-1271
20. Tohen M, Chengappa K N, Suppes T, Baker R W, Zarate C A, Bowden C L, Sachs G S, Kupfer D J, Ghaemi S N, Feldman P D, Risser R C, Evans A R, Calabrese J R (2004) Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 184: 337-345
21. Tondo L, Hennen J, Baldessarini R J (2001) Lower suicide risk with long term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 104: 163-172
22. Zarate C A Jr, Tohen M (2004) Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry 161(1): 169-171